Antimicrobial drugs in fighting against antimicrobial resistance

Frontiers in Microbiology

Volumn 7, Issue APR, 2016, Pages

  Cheng, Guyue ^a   Dai, Menghong ^a   Ahmed, Saeed ^a   Hao, Haihong ^a   Wang, Xu ^a   Yuan, Zonghui ^a  

^a HUAZHONG AGRICULTURAL UNIVERSITY   (China)

Author keywords

Antimicrobial drug; Antimicrobial resistance; Biofilm; Nanoparticles; Persisters

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIINFECTIVE AGENT; BEDAQUILINE; BETA LACTAMASE; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CLINDAMYCIN; CLOFAZIMINE; COTRIMOXAZOLE; CYTOCHROME; FOSFOMYCIN; FUSIDIC ACID; IMIDAZOPYRIDINE DERIVATIVE; KANAMYCIN; MECILLINAM; NANOPARTICLE; NITROFURANTOIN; PENICILLIN DERIVATIVE; POLYMYXIN; PRISTINAMYCIN; REACTIVE OXYGEN METABOLITE; RIFAMPICIN; SILICA NANOPARTICLE; SILVER NANOPARTICLE; STREPTOMYCIN; TEMOCILLIN; TETRACYCLINE; UBIQUINOL CYTOCHROME C REDUCTASE; UNINDEXED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; BIOFILM; BIOLOGICAL ACTIVITY; DRUG EFFICACY; DRUG SAFETY; DRUG TARGETING; ESCHERICHIA COLI; GENE MUTATION; GENE TRANSFER; GRAM NEGATIVE INFECTION; GRAM POSITIVE INFECTION; HEALTH CARE; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; PSEUDOMONAS AERUGINOSA; REVIEW; STREPTOMYCES; TOXICITY;

EID: 84966270200     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2016.00470     Document Type: Review

References (135)

1. Ali, K., Ahmed, B., Dwivedi, S., Saquib, Q., Al-Khedhairy, A. A., and Musarrat, J. (2015). Microwave accelerated green synthesis of stable silver nanoparticles with eucalyptus globulus leaf extract and their antibacterial and antibiofilm activity on clinical isolates. PLoS ONE 10:e0131178. doi: 10.1371/journal.pone.0131178.
2. Allison, K. R., Brynildsen, M. P., and Collins, J. J. (2011). Metabolite-enabled eradication of bacterial persisters by aminoglycosides. Nature 473, 216-220. doi: 10.1038/nature10069.
3. Andries, K., Verhasselt, P., Guillemont, J., Göhlmann, H. W., Neefs, J. M., Winkler, H., et al. (2005). A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis. Science 307, 223-227. doi: 10.1126/science.1106753.
4. Aramwit, P., Bang, N., Ratanavaraporn, J., and Ekgasit, S. (2014). Green synthesis of silk sericin-capped silver nanoparticles and their potent anti-bacterial activity. Nanoscale Res. Lett. 9:79. doi: 10.1186/1556-276X-9-79.
5. Arenz, S., and Wilson, D. N. (2016). Blast from the past: reassessing forgotten translation inhibitors, antibiotic selectivity, and resistance mechanisms to aid drug development. Mol. Cell 61, 3-14. doi: 10.1016/j.molcel.2015.10.019.
6. Azam, A., Ahmed, A. S., Oves, M., Khan, M. S., Habib, S. S., and Memic, A. (2012). Antimicrobial activity of metal oxide nanoparticles against Gram-positive and Gram-negative bacteria: a comparative study. Int. J. Nanomedicine 7, 6003-6009. doi: 10.2147/IJN.S35347.
7. Azizi, S., Ahmad, M., Mahdavi, M., and Abdolmohammadi, S. (2013). Preparation, characterization, and antimicrobial activities of ZnO nanoparticles/cellulose nanocrystal nanocomposites. Bioresources 8, 1841-1851. doi: 10.15376/biores.8.2.1841-1851.
8. Balamurugan, P., Hema, M., Kaur, G., Sridharan, V., Prabu, P. C., Sumana, M. N., et al. (2015). Development of a biofilm inhibitor molecule against multidrug resistant Staphylococcus aureus associated with gestational urinary tract infections. Front. Microbiol. 6:832. doi: 10.3389/fmicb.2015.00832.
9. Banin, E., Brady, K. M., and Greenberg, E. P. (2006). Chelator-induced dispersal and killing of Pseudomonas aeruginosa cells in a biofilm. Appl. Environ. Microbiol. 72, 2064-2069. doi: 10.1128/AEM.72.3.2064-2069.2006.
10. Baym, M., Stone, L. K., and Kishony, R. (2016). Multidrug evolutionary strategies to reverse antibiotic resistance. Science 351:aad3292. doi: 10.1126/science.aad3292.
11. Beloin, C., Renard, S., Ghigo, J. M., and Lebeaux, D. (2014). Novel approaches to combat bacterial biofilms. Curr. Opin. Pharmacol. 18, 61-68. doi: 10.1016/j.coph.2014.09.005.
12. Bernier, S. P., Lebeaux, D., DeFrancesco, A. S., Valomon, A., Soubigou, G., Coppée, J. Y., et al. (2013). Starvation, together with the SOS response, mediates high biofilm-specific tolerance to the fluoroquinolone ofloxacin. PLoS Genet. 9:e1003144. doi: 10.1371/journal.pgen.1003144.
13. Bibbs, R. K., Harris, R. D., Peoples, V. A., Barnett, C., Singh, S. R., Dennis, V. A., et al. (2014). Silver polyvinyl pyrrolidone nanoparticles exhibit a capsular polysaccharide influenced bactericidal effect against Streptococcus pneumoniae. Front. Microbiol. 5:665. doi: 10.3389/fmicb.2014.00665.
14. Blázquez, J. (2003). Hypermutation as a factor contributing to the acquisition of antimicrobial resistance. Clin. Infect. Dis. 37, 1201-1209. doi: 10.1086/378810.
15. Briers, Y., Walmagh, M., Grymonprez, B., Biebl, M., Pirnay, J. P., Defraine, V., et al. (2014). Art-175 is a highly efficient antibacterial against multidrug-resistant strains and persisters of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 58, 3774-3784. doi: 10.1128/AAC.02668-14.
16. Bulkley, D., Brandi, L., Polikanov, Y. S., Fabbretti, A., O'Connor, M., Gualerzi, C. O., et al. (2014). The antibiotics dityromycin and GE82832 bind protein S12 and block EF-G-catalyzed translocation. Cell Rep. 6, 357-365. doi: 10.1016/j.celrep.2013.12.024.
17. Bush, K., and Fisher, J. F. (2011). Epidemiological expansion, structural studies, and clinical challenges of new beta-lactamases from gram-negative bacteria. Annu. Rev. Microbiol. 65, 455-478. doi: 10.1146/annurev-micro-090110-102911.
18. Caly, D. L., Bellini, D., Walsh, M. A., Dow, J. M., and Ryan, R. P. (2015). Targeting cyclic di-GMP signalling: a strategy to control biofilm formation? Curr. Pharm. Des. 21, 12-24. doi: 10.2174/1381612820666140905124701.
19. Cassir, N., Rolain, J. M., and Brouqui, P. (2014). A new strategy to fight antimicrobial resistance: the revival of old antibiotics. Front. Microbiol. 5:551. doi: 10.3389/fmicb.2014.00551.
20. Chang, Q., Wang, W., Regev-Yochay, G., Lipsitch, M., and Hanage, W. P. (2015). Antibiotics in agriculture and the risk to human health: how worried should we be? Evol. Appl. 8, 240-247. doi: 10.1111/eva.12185.
21. Chauhan, A., Bernardin, A., Mussard, W., Kriegel, I., Estève, M., Ghigo, J. M., et al. (2014). Preventing biofilm formation and associated occlusion by biomimetic glycocalyxlike polymer in central venous catheters. J. Infect. Dis. 210, 1347-1356. doi: 10.1093/infdis/jiu249.
22. Chauhan, A., Lebeaux, D., Ghigo, J. M., and Beloin, C. (2012). Full and broad-spectrum in vivo eradication of catheter-associated biofilms using gentamicin-EDTA antibiotic lock therapy. Antimicrob. Agents Chemother. 56, 6310-6318. doi: 10.1128/AAC.01606-12.
23. Cheng, G., Hao, H., Xie, S., Wang, X., Dai, M., Huang, L., et al. (2014). Antibiotic alternatives: the substitution of antibiotics in animal husbandry? Front. Microbiol. 5:217. doi: 10.3389/fmicb.2014.00217.
24. Cheng, L., Weir, M. D., Xu, H. H., Antonucci, J. M., Kraigsley, A. M., Lin, N. J., et al. (2012). Antibacterial amorphous calcium phosphate nanocomposites with a quaternary ammonium dimethacrylate and silver nanoparticles. Dent. Mater. 28, 561-572. doi: 10.1016/j.dental.2012.01.005.
25. Chiang, W. C., Nilsson, M., Jensen, P. Ø., Høiby, N., Nielsen, T. E., Givskov, M., et al. (2013). Extracellular DNA shields against aminoglycosides in Pseudomonas aeruginosa biofilms. Antimicrob. Agents Chemother. 57, 2352-2361. doi: 10.1128/AAC.00001-13.
26. Chitra, K., and Annadurai, G. (2013). Antimicrobial activity of wet chemically engineered spherical shaped ZnO nanoparticles on food borne pathogen. Int. Food Res. J. 20, 59-64.
27. Conibear, T. C., Collins, S. L., and Webb, J. S. (2009). Role of mutation in Pseudomonas aeruginosa biofilm development. PLoS ONE 4:e6289. doi: 10.1371/journal.pone.0006289.
28. Conlon, B. P., Nakayasu, E. S., Fleck, L. E., LaFleur, M. D., Isabella, V. M., Coleman, K., et al. (2013). Activated ClpP kills persisters and eradicates a chronic biofilm infection. Nature 503, 365-370. doi: 10.1038/nature12790.
29. Darouiche, R. O., Mansouri, M. D., Gawande, P. V., and Madhyastha, S. (2009). Antimicrobial and antibiofilm efficacy of triclosan and DispersinB combination. J. Antimicrob. Chemother. 64, 88-93. doi: 10.1093/jac/dkp158.
30. D'Costa, V. M., McGrann, K. M., Hughes, D. W., and Wright, G. D. (2006). Sampling the antibiotic resistome. Science 311, 374-377. doi: 10.1126/science.1120800.
31. De Jong, W. H., and Borm, P. J. (2008). Drug delivery and nanoparticles:applications and hazards. Int. J. Nanomedicine 3, 133-149. doi: 10.2147/IJN.S596.
32. de la Fuente-Núñez, C., Reffuveille, F., Haney, E. F., Straus, S. K., and Hancock, R. E. (2014). Broad-spectrum anti-biofilm peptide that targets a cellular stress response. PLoS Pathog. 10:e1004152. doi: 10.1371/journal.ppat.1004152.
33. Domingues, S., Harms, K., Fricke, W. F., Johnsen, P. J., da Silva, G. J., and Nielsen, K. M. (2012). Natural transformation facilitates transfer of transposons, integrons and gene cassettes between bacterial species. PLoS Pathog. 8:e1002837. doi: 10.1371/journal.ppat.1002837.
34. dos Santos, C. A., Seckler, M. M., Ingle, A. P., Gupta, I., Galdiero, S., Galdiero, M., et al. (2013). Silver nanoparticles: therapeutical uses, toxicity, and safety issues. J. Pharm. Sci. 103, 1931-1944. doi: 10.1002/jps.24001.
35. Draper, L. A., Cotter, P. D., Hill, C., and Ross, R. P. (2015). Lantibiotic resistance. Microbiol. Mol. Biol. Rev. 79, 171-191. doi: 10.1128/MMBR.00051-14.
36. Durán, N., Durán, M., de Jesus, M. B., Seabra, A. B., Fávaro, W. J., and Nakazato, G. (2016). Silver nanoparticles: a new view on mechanistic aspects on antimicrobial activity. Nanomedicine 12, 789-799. doi: 10.1016/j.nano.2015.11.016.
37. El Kassas, H. Y., and Attia, A. A. (2014). Bactericidal application and cytotoxic activity of biosynthesized silver nanoparticles with an extract of the red seaweed Pterocladiella capillacea on the HepG2 cell line. Asian Pac. J. Cancer Prev. 15, 1299-1306. doi: 10.7314/APJCP.2014.15.3.1299.
38. El-Sheekh, M. M., and El-Kassas, H. Y. (2014). Application of biosynthesized silver nanoparticles against a cancer promoter cyanobacterium, Microcystis aeruginosa. Asian Pac. J. Cancer Prev. 15, 6773-6779. doi: 10.7314/APJCP.2014.15.16.6773.
39. EMA (2013). New EMA Guidance on Development of Antibacterials to Help in the Fight against Multidrug-Resistant Pathogens. European Medicines Agency. Available online at: http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2013/11/news_detail_001944.jsp&mid=WC0b01ac058004d5c1.
40. Fabrega, J., Renshaw, J. C., and Lead, J. R. (2009). Interactions of silver nanoparticles with Pseudomonas putida biofilms. Environ. Sci. Technol. 43, 9004-9009. doi: 10.1021/es901706j.
41. Farha, M. A., and Brown, E. D. (2016). Strategies for target identification of antimicrobial natural products. Nat. Prod. Rep. doi: 10.1039/C5NP00127G. [Epub ahead of print].
42. FDA (2010). US Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER). Guidance for industry antibacterial drug products: use of noninferiority trials to support approval. Available online at: http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm070951.pdf.
43. Foley, T. L., and Simeonov, A. (2012). Targeting iron assimilation to develop new antibacterials. Expert Opin. Drug Discov. 7, 831-847. doi: 10.1517/17460441.2012.708335.
44. Franci, G., Falanga, A., Galdiero, S., Palomba, L., Rai, M., Morelli, G., et al. (2015). Silver nanoparticles as potential antibacterial agents. Molecules 20, 8856-8874. doi: 10.3390/molecules20058856.
45. Germain, E., Roghanian, M., Gerdes, K., and Maisonneuve, E. (2015). Stochastic induction of persister cells by HipA through (p)ppGpp-mediated activation of mRNA endonucleases. Proc. Natl. Acad. Sci. U.S.A. 112, 5171-5176. doi: 10.1073/pnas.1423536112.
46. Gillings, M. R., Holley, M. P., and Stokes, H. W. (2009). Evidence for dynamic exchange of qac gene cassettes between class 1 integrons and other integrons in freshwater biofilms. FEMS Microbiol. Lett. 296, 282-288. doi: 10.1111/j.1574-6968.2009.01646.x.
47. Gillings, M. R., and Stokes, H. W. (2012). Are humans increasing bacterial evolvability? Trends Ecol. Evol. 27, 346-352. doi: 10.1016/j.tree.2012.02.006.
48. Henriques-Normark, B., and Normark, S. (2014). Bacterial vaccines and antibiotic resistance. Ups. J. Med. Sci. 119, 205-208. doi: 10.3109/03009734.2014.903324.
49. Hook, A. L., Chang, C. Y., Yang, J., Luckett, J., Cockayne, A., Atkinson, S., et al. (2012). Combinatorial discovery of polymers resistant to bacterial attachment. Nat. Biotechnol. 30, 868-875. doi: 10.1038/nbt.2316.
50. Hooper, D. C., and Jacoby, G. A. (2015). Mechanisms of drug resistance: quinolone resistance. Ann. N.Y. Acad. Sci. 1354, 12-31. doi: 10.1111/nyas.12830.
51. Hymes, S. R., Randis, T. M., Sun, T. Y., and Ratner, A. J. (2013). DNase inhibits Gardnerella vaginalis biofilms in vitro and in vivo. J. Infect. Dis. 207, 1491-1497. doi: 10.1093/infdis/jit047.
52. Islam, M. S., Larimer, C., Ojha, A., and Nettleship, I. (2013). Antimycobacterial efficacy of silver nanoparticles as deposited on porous membrane filters. Mater. Sci. Eng. 33, 4575-4581. doi: 10.1016/j.msec.2013.07.013.
53. Jaiswal, S., Bhattacharya, K., McHale, P., and Duffy, B. (2015). Dual effects of beta-cyclodextrin-stabilised silver nanoparticles: enhanced biofilm inhibition and reduced cytotoxicity. J. Mater. Sci. 26:5367. doi: 10.1007/s10856-014-5367-1.
54. Kalishwaralal, K., BarathManiKanth, S., Pandian, S. R., Deepak, V., and Gurunathan, S. (2010). Silver nanoparticles impede the biofilm formation by Pseudomonas aeruginosa and Staphylococcus epidermidis. Colloids Surfaces 79, 340-344. doi: 10.1016/j.colsurfb.2010.04.014.
55. Kandi, V., and Kandi, S. (2015). Antimicrobial properties of nanomolecules: potential candidates as antibiotics in the era of multi-drug resistance. Epidemiol. Health 37:e2015020. doi: 10.4178/epih/e2015020.
56. Khan, S. N., and Khan, A. U. (2016). Breaking the Spell: Combating Multidrug Resistant 'Superbugs'. Front. Microbiol. 7:174. doi: 10.3389/fmicb.2016.00174.
57. Khan, W., Bernier, S. P., Kuchma, S. L., Hammond, J. H., Hasan, F., and O'Toole, G. A. (2010). Aminoglycoside resistance of Pseudomonas aeruginosa biofilms modulated by extracellular polysaccharide. Int. Microbiol. 13, 207-212. doi: 10.2436/20.1501.01.127.
58. Kim, J. S., Kuk, E., Yu, K. N., Kim, J. H., Park, S. J., Lee, H. J., et al. (2007). Antimicrobial effects of silver nanoparticles. Nanomedicine 3, 95-101. doi: 10.1016/j.nano.2006.12.001.
59. King, D. T., and Strynadka, N. C. (2013). Targeting metallo-beta-lactamase enzymes in antibiotic resistance. Future Med. Chem. 5, 1243-1263. doi: 10.4155/fmc.13.55.
60. 2 nanoparticles. Pol. J. Microbiol. 64, 137-142.
61. Król, E., de Sousa Borges, A., da Silva, I., Polaquini, C. R., Regasini, L. O., Ferreira, H., et al. (2015). Antibacterial activity of alkyl gallates is a combination of direct targeting of FtsZ and permeabilization of bacterial membranes. Front. Microbiol. 6:390. doi: 10.3389/fmicb.2015.00390.
62. Lebeaux, D., Chauhan, A., Létoffé, S., Fischer, F., de Reuse, H., Beloin, C., et al. (2014a). pH-mediated potentiation of aminoglycosides kills bacterial persisters and eradicates in vivo biofilms. J. Infect. Dis. 210, 1357-1366. doi: 10.1093/infdis/jiu286.
63. Lebeaux, D., Chauhan, A., Rendueles, O., and Beloin, C. (2013). From in vitro to in vivo models of bacterial biofilm-related infections. Pathogens 2, 288-356. doi: 10.3390/pathogens2020288.
64. Lebeaux, D., Ghigo, J. M., and Beloin, C. (2014b). Biofilm-related infections: bridging the gap between clinical management and fundamental aspects of recalcitrance toward antibiotics. Microbiol. Mol. Biol. Rev. 78, 510-543. doi: 10.1128/MMBR.00013-14.
65. Lekshmi, N. C., Sumi, S. B., Viveka, S., Jeeva, S., and Brindha, J. R. (2012). Antibacterial activity of nanoparticles from Allium sp. J. Microbiol. Biotechnol. Res. 2, 115-119.
66. Lewis, K. (2008). Multidrug tolerance of biofilms and persister cells. Curr. Top. Microbiol. Immunol. 322, 107-131. doi: 10.1007/978-3-540-75418-3_6.
67. Lewis, K. (2010). Persister cells. Annu. Rev. Microbiol. 64, 357-372. doi: 10.1146/annurev.micro.112408.134306.
68. Li, X. Z., Plésiat, P., and Nikaido, H. (2015). The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria. Clin. Microbiol. Rev. 28, 337-418. doi: 10.1128/CMR.00117-14.
69. Lima, E., Guerra, R., Lara, V., and Guzmán, A. (2013). Gold nanoparticles as efficient antimicrobial agents for Escherichia coli and Salmonella typhi. Chem. Cent. J. 7:11. doi: 10.1186/1752-153X-7-11.
70. Lo, A. W., Van de Water, K., Gane, P. J., Chan, A. W., Steadman, D., Stevens, K., et al. (2014). Suppression of type 1 pilus assembly in uropathogenic Escherichia coli by chemical inhibition of subunit polymerization. J. Antimicrob. Chemother. 69, 1017-1026. doi: 10.1093/jac/dkt467.
71. Losasso, C., Belluco, S., Cibin, V., Zavagnin, P., Micetic, I., Gallocchio, F., et al. (2014). Antibacterial activity of silver nanoparticles: sensitivity of different Salmonella serovars. Front. Microbiol. 5:227. doi: 10.3389/fmicb.2014.00227.
72. Maisonneuve, E., and Gerdes, K. (2014). Molecular mechanisms underlying bacterial persisters. Cell 157, 539-548. doi: 10.1016/j.cell.2014.02.050.
73. Markowska, K., Grudniak, A. M., and Wolska, K. I. (2013). Silver nanoparticles as an alternative strategy against bacterial biofilms. Acta Biochim. Pol. 60, 523-530.
74. Martinez-Gutierrez, F., Boegli, L., Agostinho, A., Sánchez, E. M., Bach, H., Ruiz, F., et al. (2013). Anti-biofilm activity of silver nanoparticles against different microorganisms. Biofouling 29, 651-660. doi: 10.1080/08927014.2013.794225.
75. Miller, K. P., Wang, L., Chen, Y. P., Pellechia, P. J., Benicewicz, B. C., and Decho, A. W. (2015). Engineering nanoparticles to silence bacterial communication. Front. Microbiol. 6:189. doi: 10.3389/fmicb.2015.00189.
76. Mohanty, S., Mishra, S., Jena, P., Jacob, B., Sarkar, B., and Sonawane, A. (2012). An investigation on the antibacterial, cytotoxic, and antibiofilm efficacy of starch-stabilized silver nanoparticles. Nanomedicine 8, 916-924. doi: 10.1016/j.nano.2011.11.007.
77. Morita, Y., Tomida, J., and Kawamura, Y. (2014). Responses of Pseudomonas aeruginosa to antimicrobials. Front. Microbiol. 4:422. doi: 10.3389/fmicb.2013.00422.
78. Morones-Ramirez, J. R., Winkler, J. A., Spina, C. S., and Collins, J. J. (2013). Silver enhances antibiotic activity against gram-negative bacteria. Sci. Transl. Med. 5, 190ra181. doi: 10.1126/scitranslmed.3006276.
79. Mouton, J. W., Ambrose, P. G., Canton, R., Drusano, G. L., Harbarth, S., MacGowan, A., et al. (2011). Conserving antibiotics for the future: new ways to use old and new drugs from a pharmacokinetic and pharmacodynamic perspective. Drug Resist. Updat. 14, 107-117. doi: 10.1016/j.drup.2011.02.005.
80. Mouton, J. W., Brown, D. F., Apfalter, P., Cantón, R., Giske, C. G., Ivanova, M., et al. (2012). The role of pharmacokinetics/pharmacodynamics in setting clinical MIC breakpoints: the EUCAST approach. Clin. Microbiol. Infect. 18, E37-E45. doi: 10.1111/j.1469-0691.2011.03752.x.
81. Mukherje, M. (2014). In vitro antimicrobial activity of polyacrylamide doped magnetic iron oxide nanoparticles. Int. J. Mater. Mech. Manuf. 2, 64-66. doi: 10.7763/ijmmm.2014.v2.101.
82. Mulcahy, H., Charron-Mazenod, L., and Lewenza, S. (2008). Extracellular DNA chelates cations and induces antibiotic resistance in Pseudomonas aeruginosa biofilms. PLoS Pathog. 4:e1000213. doi: 10.1371/journal.ppat.1000213.
83. Muller, A. E., Theuretzbacher, U., and Mouton, J. W. (2015). Use of old antibiotics now and in the future from a pharmacokinetic/pharmacodynamic perspective. Clin. Microbiol. Infect. 21, 881-885. doi: 10.1016/j.cmi.2015.06.007.
84. Murima, P., McKinney, J. D., and Pethe, K. (2014). Targeting bacterial central metabolism for drug development. Chem. Biol. 21, 1423-1432. doi: 10.1016/j.chembiol.2014.08.020.
85. Nam, K. Y. (2014). Characterization and bacterial anti-adherent effect on modified PMMA denture acrylic resin containing platinum nanoparticles. J. Adv. Prosthodont. 6, 207-214. doi: 10.4047/jap.2014.6.3.207.
86. Nguyen, D., Joshi-Datar, A., Lepine, F., Bauerle, E., Olakanmi, O., Beer, K., et al. (2011). Active starvation responses mediate antibiotic tolerance in biofilms and nutrient-limited bacteria. Science 334, 982-986. doi: 10.1126/science.1211037.
87. Nikaido, H. (2003). Molecular basis of bacterial outer membrane permeability revisited. Microbiol. Mol. Biol. Rev. 67, 593-656. doi: 10.1128/MMBR.67.4.593-656.2003.
88. Oldfield, E., and Feng, X. (2014). Resistance-resistant antibiotics. Trends Pharmacol. Sci. 35, 664-674. doi: 10.1016/j.tips.2014.10.007.
89. Opperman, T. J., and Nguyen, S. T. (2015). Recent advances toward a molecular mechanism of efflux pump inhibition. Front. Microbiol. 6:421. doi: 10.3389/fmicb.2015.00421.
90. Page, M. G., and Bush, K. (2014). Discovery and development of new antibacterial agents targeting Gram-negative bacteria in the era of pandrug resistance: is the future promising? Curr. Opin. Pharmacol. 18, 91-97. doi: 10.1016/j.coph.2014.09.008.
91. Page, M. G., Dantier, C., and Desarbre, E. (2010). In vitro properties of BAL3(0072). a novel siderophore sulfactam with activity against multiresistant gram-negative bacilli. Antimicrob. Agents Chemother. 54, 2291-2302. doi: 10.1128/AAC.01525-09.
92. Palanisamy, N. K., Ferina, N., Amirulhusni, A. N., Mohd-Zain, Z., Hussaini, J., Ping, L. J., et al. (2014). Antibiofilm properties of chemically synthesized silver nanoparticles found against Pseudomonas aeruginosa. J. Nanobiotechnology 12:2. doi: 10.1186/1477-3155-12-2.
93. Pan, J., and Ren, D. (2013). Structural effects on persister control by brominated furanones. Bioorg. Med. Chem. Lett. 23, 6559-6562. doi: 10.1016/j.bmcl.2013.10.070.
94. Parasion, S., Kwiatek, M., Gryko, R., Mizak, L., and Malm, A. (2014). Bacteriophages as an alternative strategy for fighting biofilm development. Pol. J. Microbiol. 63, 137-145.
95. Park, H. J., Park, S., Roh, J., Kim, S., Choi, K., Yi, J., et al. (2013). Biofilm-inactivating activity of silver nanoparticles: a comparison with silver ions. J. Ind. Eng. Chem. 19, 614-619. doi: 10.1016/j.jiec.2012.09.013.
96. Penesyan, A., Gillings, M., and Paulsen, I. T. (2015). Antibiotic discovery: combatting bacterial resistance in cells and in biofilm communities. Molecules 20, 5286-5298. doi: 10.3390/molecules20045286.
97. Pethe, K., Bifani, P., Jang, J., Kang, S., Park, S., Ahn, S., et al. (2013). Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis. Nat. Med. 19, 1157-1160. doi: 10.1038/nm.3262.
98. Prabhu, S., and Poulose, E. K. (2012). Silver nanoparticles: mechanism of antimicrobial action, synthesis, medical applications, and toxicity effects. Int. Nano Lett. 2:32. doi: 10.1186/2228-5326-2-32.
99. Pulcini, C., Bush, K., Craig, W. A., Frimodt-Møller, N., Grayson, M. L., Mouton, J. W., et al. (2012). Forgotten antibiotics: an inventory in Europe, the United States, Canada, and Australia. Clin. Infect. Dis. 54, 268-274. doi: 10.1093/cid/cir838.
100. Pule, C. M., Sampson, S. L., Warren, R. M., Black, P. A., van Helden, P. D., Victor, T. C., et al. (2016). Efflux pump inhibitors: targeting mycobacterial efflux systems to enhance TB therapy. J. Antimicrob. Chemother. 71, 17-26. doi: 10.1093/jac/dkv316.
101. Radzig, M. A., Nadtochenko, V. A., Koksharova, O. A., Kiwi, J., Lipasova, V. A., and Khmel, I. A. (2013). Antibacterial effects of silver nanoparticles on gram-negative bacteria: influence on the growth and biofilms formation, mechanisms of action. Colloids Surfaces 102, 300-306. doi: 10.1016/j.colsurfb.2012.07.039.
102. Rampioni, G., Leoni, L., and Williams, P. (2014). The art of antibacterial warfare: deception through interference with quorum sensing-mediated communication. Bioorg. Chem. 55, 60-68. doi: 10.1016/j.bioorg.2014.04.005.
103. Rao, C. V. S., De Waelheyns, E., Economou, A., and Anné, J. (2014). Antibiotic targeting of the bacterial secretory pathway. Biochim. Biophy. Acta 1843, 1762-1783. doi: 10.1016/j.bbamcr.2014.02.004.
104. Roe, D., Karandikar, B., Bonn-Savage, N., Gibbins, B., and Roullet, J. B. (2008). Antimicrobial surface functionalization of plastic catheters by silver nanoparticles. J. Antimicrob. Chemother. 61, 869-876. doi: 10.1093/jac/dkn034.
105. Sambanthamoorthy, K., Sloup, R. E., Parashar, V., Smith, J. M., Kim, E. E., Semmelhack, M. F., et al. (2012). Identification of small molecules that antagonize diguanylate cyclase enzymes to inhibit biofilm formation. Antimicrob. Agents Chemother. 56, 5202-5211. doi: 10.1128/AAC.01396-12.
106. Sass, P., and Brötz-Oesterhelt, H. (2013). Bacterial cell division as a target for new antibiotics. Curr. Opin. Microbiol. 16, 522-530. doi: 10.1016/j.mib.2013.07.006.
107. Seil, J. T., and Webster, T. J. (2012). Antimicrobial applications of nanotechnology: methods and literature. Int. J. Nanomedicine 7, 2767-2781. doi: 10.2147/IJN.S24805.
108. Shaw, K. J., Rather, P. N., Hare, R. S., and Miller, G. H. (1993). Molecular genetics of aminoglycoside resistance genes and familial relationships of the aminoglycoside-modifying enzymes. Microbiol. Rev. 57, 138-163.
109. Shetye, G. S., Singh, N., Jia, C., Nguyen, C. D., Wang, G., and Luk, Y. Y. (2014). Specific maltose derivatives modulate the swarming motility of nonswarming mutant and inhibit bacterial adhesion and biofilm formation by Pseudomonas aeruginosa. Chembiochem 15, 1514-1523. doi: 10.1002/cbic.201402093.
110. Singh, N., Saha, P., Rajkumar, K., and Abraham, J. (2014). Biosynthesis of silver and selenium nanoparticles by Bacillus sp. JAPSK2 and evaluation of antimicrobial activity. Der. Pharm. Lett. 6, 175-181.
111. Smith, R. S., Zhang, Z., Bouchard, M., Li, J., Lapp, H. S., Brotske, G. R., et al. (2012). Vascular catheters with a nonleaching poly-sulfobetaine surface modification reduce thrombus formation and microbial attachment. Sci. Transl. Med. 4, 153ra132. doi: 10.1126/scitranslmed.3004120.
112. Subramenium, G. A., Vijayakumar, K., and Pandian, S. K. (2015). Limonene inhibits streptococcal biofilm formation by targeting surface-associated virulence factors. J. Med. Microbiol. 64, 879-890. doi: 10.1099/jmm.0.000105.
113. Sun, J., Deng, Z., and Yan, A. (2014). Bacterial multidrug efflux pumps: mechanisms, physiology and pharmacological exploitations. Biochem. Biophys. Res. Commun. 453, 254-267. doi: 10.1016/j.bbrc.2014.05.090.
114. Sutcliffe, J. A. (2011). Antibiotics in development targeting protein synthesis. Ann. N.Y. Acad. Sci. 1241, 122-152. doi: 10.1111/j.1749-6632.2011.06323.x.
115. Thekkae Padil, V. V., and Cerník, M. (2013). Green synthesis of copper oxide nanoparticles using gum karaya as a biotemplate and their antibacterial application. Int. J. Nanomedicine 8, 889-898. doi: 10.2147/IJN.S40599.
116. Tillotson, G. S., and Theriault, N. (2013). New and alternative approaches to tackling antibiotic resistance. F1000Prime Rep. 5:51. doi: 10.12703/P5-51.
117. Totsika, M., Kostakioti, M., Hannan, T. J., Upton, M., Beatson, S. A., Janetka, J. W., et al. (2013). A FimH inhibitor prevents acute bladder infection and treats chronic cystitis caused by multidrug-resistant uropathogenic Escherichia coli ST131. J. Infect. Dis. 208, 921-928. doi: 10.1093/infdis/jit245.
118. Townsend, J. P., Nielsen, K. M., Fisher, D. S., and Hartl, D. L. (2003). Horizontal acquisition of divergent chromosomal DNA in bacteria: effects of mutator phenotypes. Genetics 164, 13-21.
119. Urfer, M., Bogdanovic, J., Lo Monte, F., Moehle, K., Zerbe, K., Omasits, U., et al. (2016). A peptidomimetic antibiotic targets outer membrane proteins and disrupts selectively the outer membrane in Escherichia coli. J. Biol. Chem. 291, 1921-1932. doi: 10.1074/jbc.M115.691725.
120. Vardanyan, Z., Gevorkyan, V., Ananyan, M., Vardapetyan, H., and Trchounian, A. (2015). Effects of various heavy metal nanoparticles on Enterococcus hirae and Escherichia coli growth and proton-coupled membrane transport. J. Nanobiotechnol. 13, 69. doi: 10.1186/s12951-015-0131-3.
121. Veerachamy, S., Yarlagadda, T., Manivasagam, G., and Yarlagadda, P. K. (2014). Bacterial adherence and biofilm formation on medical implants: a review. Proc. Inst. Mech. Eng. 228, 1083-1099. doi: 10.1177/0954411914556137.
122. Venter, H., Mowla, R., Ohene-Agyei, T., and Ma, S. (2015). RND-type drug efflux pumps from Gram-negative bacteria: molecular mechanism and inhibition. Front. Microbiol. 6:377. doi: 10.3389/fmicb.2015.00377.
123. Wexselblatt, E., Kaspy, I., Glaser, G., Katzhendler, J., and Yavin, E. (2013). Design, synthesis and structure-activity relationship of novel Relacin analogs as inhibitors of Rel proteins. Eur. J. Med. Chem. 70, 497-504. doi: 10.1016/j.ejmech.2013.10.036.
124. Wexselblatt, E., Oppenheimer-Shaanan, Y., Kaspy, I., London, N., Schueler-Furman, O., Yavin, E., et al. (2012). Relacin, a novel antibacterial agent targeting the Stringent Response. PLoS Pathog. 8:e1002925. doi: 10.1371/journal.ppat.1002925.
125. Wolska, K. I., Grzes, K., and Kurek, A. (2012). Synergy between novel antimicrobials and conventional antibiotics or bacteriocins. Pol. J. Microbiol. 61, 95-104.
126. Xu, H., Qu, F., Xu, H., Lai, W., Andrew Wang, Y., Aguilar, Z. P., et al. (2012). Role of reactive oxygen species in the antibacterial mechanism of silver nanoparticles on Escherichia coli O157:H7. Biometals 25, 45-53. doi: 10.1007/s10534-011-9482-x.
127. Yu, L., Zhang, Y., Zhang, B., and Liu, J. (2014). Enhanced antibacterial activity of silver nanoparticles/halloysite nanotubes/graphene nanocomposites with sandwich-like structure. Sci. Rep. 4, 45-51. doi: 10.1038/srep04551.
128. Zhanel, G. G., Lawson, C. D., Zelenitsky, S., Findlay, B., Schweizer, F., Adam, H., et al. (2012). Comparison of the next-generation aminoglycoside plazomicin to gentamicin, tobramycin and amikacin. Expert Rev. Anti Infect. Ther. 10, 459-473. doi: 10.1586/eri.12.25.
129. Zhang, K., Wang, S., Zhou, X., Xu, H. H., Weir, M. D., Ge, Y., et al. (2015). Effect of antibacterial dental adhesive on multispecies biofilms formation. J. Dent. Res. 94, 622-629. doi: 10.1177/0022034515571416.
130. Zhang, L., and Mah, T. F. (2008). Involvement of a novel efflux system in biofilm-specific resistance to antibiotics. J. Bacteriol. 190, 4447-4452. doi: 10.1128/JB.01655-07.
131. Zhang, L., Pornpattananangku, D., Hu, C. M., and Huang, C. M. (2010). Development of nanoparticles for antimicrobial drug delivery. Curr. Med. Chem. 17, 585-594. doi: 10.2174/092986710790416290.
132. Zhang, W., and Li, C. (2016). Exploiting quorum sensing interfering strategies in gram-negative bacteria for the enhancement of environmental applications. Front. Microbiol. 6:1535. doi: 10.3389/fmicb.2015.01535.
133. Zheng, Y., Li, J., Liu, X., and Sun, J. (2012). Antimicrobial and osteogenic effect of Ag-implanted titanium with a nanostructured surface. Int. J. Nanomedicine 7, 875-884. doi: 10.2147/IJN.S28450.
134. Zhou, Y., Kong, Y., Kundu, S., Cirillo, J. D., and Liang, H. (2012). Antibacterial activities of gold and silver nanoparticles against Escherichia coli and Bacillus Calmette-Guerin. J. Nanobiotechnology 10:19. doi: 10.1186/1477-3155-10-19.
135. Zhu, J., and Kaufmann, G. F. (2013). Quo vadis quorum quenching? Curr. Opin. Pharmacol. 13, 688-698. doi: 10.1016/j.coph.2013.07.003.